Medtech Money --- Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective

• In this episode, Giovanni and Sascha discuss how he became the Managing Partner at SHS, where they focus from a stage of company and geographical area, the hardline of having revenue before they invest, the major differences of going public in the US and Europe for later stage companies, the affect of EU MDR on the region and innovation, their due diligence process, and more.
• Sascha Alilovic LinkedIn
• SHS Website
• Giovanni Lauricella LinkedIn
• Project Medtech LinkedIn
• Project Medtech Website